Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Atorvastatin approved in Canada

March 11, 1997

Biogen and CV Therapeutics codevelop cardiovascular therapy

March 11, 1997

Na+/K+-exchange inhibitors from Merck KGaA

March 11, 1997

Merck KGaA's new ET antagonists

March 11, 1997

Prostaglandin derivatives from Ono

March 11, 1997

Potent, long-acting ETA antagonist described by Zeneca

March 10, 1997

Merck KGaA discloses ET antagonists

March 10, 1997

OXIS completes preclinicals of restenosis treatment

March 7, 1997

Watson's mexiletine approved

March 6, 1997

Dual NEP/ECE inhibitor for heart failure

March 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...